Sparsentan (sparsentan) launch status and purchasing guide in China in 2024

With the continuous advancement of medical technology, new treatment drugs are constantly coming out, bringing more treatment options to patients. Spasentan (sparsentan), an oral specific dual endothelin receptor antagonist, has been approved for the treatment of IgA nephropathy (IgAN). It protects kidney function by inhibiting the effects of endothelin-1 and angiotensin II, slowing the progression of kidney disease and reducing proteinuria levels. At present, this drug has attracted more attention from domestic patients. So,Will sparsentan (sparsentan) be launched in China in 2024? How to buy it?

It is reported that sparsentan (sparsentan) has not yet been approved for marketing by the National Medical Products Administration (NMPA) in China. For patients who urgently need treatment with the drug, purchasing the drug overseas may be an option. However, purchasing drugs overseas involves many steps, and patients must be cautious. First of all, it is crucial to choose a reliable drug purchasing channel. It is recommended to choose guaranteed formal channels. Patients can consult some qualified and reputable overseas medical institutions. These institutions usually have direct contact with pharmaceutical companies and can ensure the reliability of drug sources.

Secondly, during the process of purchasing drugs, patients need to pay attention to distinguishing the authenticity of the drugs. Verification can be carried out by checking the outer packaging of the drug, the included instructions, and scanning the anti-counterfeiting label. If possible, you can consult a professional doctor or pharmacist to get more information on how to identify the authenticity of the drug.

Regarding the price of sparsentan, the original drug sells for a higher price, which may put some pressure on patients with limited financial conditions. But fortunately, there are more affordable generic versions of Lucius available in overseas markets. The specification of this generic drug is 400mg*30 tablets, and a box is priced at more than 7,000 yuan, providing an affordable and feasible treatment option for patients with limited financial conditions.

Finally, no matter which drug is chosen, patients should consult a professional doctor or pharmacist before use. They can provide personalized medication suggestions based on the patient's specific conditions and needs to ensure the rationality and safety of drug use.

In short, although sparsentane is not yet on the market in China, patients and family members can obtain the drug through overseas purchase. When purchasing drugs, be sure to carefully choose reliable drug purchasing channels, pay attention to distinguishing the authenticity of drugs, and consult a professional doctor or pharmacist before use.